MEP Lamberts Says AstraZeneca Treating EU `Unfairly'

Philip Lombard, a member of the European Parliament, discusses the EU's challenges with vaccine rollout, focusing on issues with AstraZeneca's delivery commitments. He refutes claims of nationalism and highlights discrepancies in how AstraZeneca treats the EU compared to other customers. The discussion touches on potential double-booking of vaccine supplies and the impact of Brexit on the UK's efficient vaccine rollout. Lombard emphasizes that the EU is the damaged party due to AstraZeneca's actions, not due to global supply issues.

What is the main issue the European Union is facing with its vaccine rollout?

• Inefficient distribution channels

• Nationalism within EU member states

• Overpromising and underdelivering by a pharma company

• Lack of vaccine supply globally

What specific problem is highlighted with AstraZeneca's vaccine distribution?

• Poor vaccine efficacy

• High vaccine prices

• Double-booking vaccine supplies

• Lack of communication with customers

How has AstraZeneca been accused of treating the EU differently?

• By fulfilling promises to other customers but not the EU

• By providing more vaccines to the EU than promised

• By prioritizing EU deliveries over others

• By offering discounts to EU countries

What is a major challenge in ramping up vaccine production according to the discussion?

• Lack of raw materials

• Unexpected production snags

• Insufficient workforce

• Regulatory hurdles

What is the perceived impact of Brexit on the UK's vaccine rollout?

• It has improved the rollout efficiency

• It has made the rollout less efficient

• It has had no impact on the rollout

• It has caused delays in vaccine approval

How does the UK's vaccine rollout compare to that of EU member states?

• It is slower

• It is more efficient

• It is equally efficient

• It is less efficient

What is the stance of the speaker on the UK's vaccine rollout performance?

• It is a result of better resources

• It is because of fewer regulations

• It is due to Brexit

• It is unrelated to EU membership